載入...

Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside outside the Peptide Interaction Site

The peptide fusion inhibitor (PFI) enfuvirtide is the first of a new class of entry inhibitors to receive FDA approval. We previously determined the susceptibility of 55 PFI-naïve-patient isolates to enfuvirtide and a second peptide inhibitor, T-649. Seven of the 55 viral isolates were insusceptible...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Heil, Marintha L., Decker, Julie M., Sfakianos, Jeffrey N., Shaw, George M., Hunter, Eric, Derdeyn, Cynthia A.
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2004
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC434069/
https://ncbi.nlm.nih.gov/pubmed/15220433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.14.7582-7589.2004
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!